Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Rodriguez-Otero

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2011
Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatmentAliénor Xhaard, Vanderson Rocha, Benjamin Bueno, et al.
British Journal of Haematology|August 4, 2011
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 familyPaula Rodriguez-Otero, José Román-Gómez, Amaia Vilas-Zornoza, et al.
Blood|May 5, 2012
Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host diseasePaula Rodriguez-Otero, Raphael Porcher, Régis Peffault de Latour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcomeLise Willems, Raphaël Porcher, Matthieu Lafaurie, et al.
Cancer Science|October 31, 2009
Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemiaVanesa Martín, Ana Valencia, Xabier Agirre, et al.
Blood Advances|March 27, 2026
Idecabtagene vicleucel manufacturing and clinical value of out of specification products in relapsed and refractory MMSurbhi Sidana, Yi Lin, Andrew J Cowan, et al.
British Journal of Haematology|September 23, 2024
A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodiesAintzane Zabaleta, Laura Blanco, Peter S Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple MyelomaFredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Theranostics|August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different InstitutionsConstantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Cancers|April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET BiomarkersMaria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2011
Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatmentAliénor Xhaard, Vanderson Rocha, Benjamin Bueno, et al.
British Journal of Haematology|August 4, 2011
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 familyPaula Rodriguez-Otero, José Román-Gómez, Amaia Vilas-Zornoza, et al.
Blood|May 5, 2012
Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host diseasePaula Rodriguez-Otero, Raphael Porcher, Régis Peffault de Latour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcomeLise Willems, Raphaël Porcher, Matthieu Lafaurie, et al.
Cancer Science|October 31, 2009
Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemiaVanesa Martín, Ana Valencia, Xabier Agirre, et al.
Blood Advances|March 27, 2026
Idecabtagene vicleucel manufacturing and clinical value of out of specification products in relapsed and refractory MMSurbhi Sidana, Yi Lin, Andrew J Cowan, et al.
British Journal of Haematology|September 23, 2024
A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodiesAintzane Zabaleta, Laura Blanco, Peter S Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple MyelomaFredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Theranostics|August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different InstitutionsConstantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Cancers|April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET BiomarkersMaria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Pageof 8